CHATSWORTH, Calif.--(BUSINESS WIRE)--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a manufacturer and marketer of automated IVD urinalysis systems and medical devices used in hospitals and clinical reference laboratories worldwide, announced today that its Board of Directors has amended its stockholders’ Rights Agreement to refresh and strengthen the Company’s anti-takeover measures as part of the Company’s defense strategy against the possibility of an unsolicited, hostile takeover.
